Data:
{
"symbol": "CYTK",
"price": 61.87,
"marketCap": 7698669710,
"beta": 0.36,
"lastDividend": 0,
"range": "54.3-88.31",
"change": -0.83,
"changePercentage": -1.32376,
"volume": 570640.22581,
"averageVolume": 2048917,
"companyName": "Cytokinetics, Incorporated",
"currency": "USD",
"cik": "0001061983",
"isin": "US23282W6057",
"cusip": "23282W605",
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.cytokinetics.com",
"description": "Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.",
"ceo": "Robert I. Blum",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "673",
"phone": "650 624 3000",
"address": "350 Oyster Point Boulevard",
"city": "South San Francisco",
"state": "CA",
"zip": "94080",
"image": "https://images.financialmodelingprep.com/symbol/CYTK.png",
"ipoDate": "2004-04-26",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "CYTK",
"name": "Cytokinetics, Incorporated",
"price": 61.88,
"changePercentage": -1.30781,
"change": -0.82,
"volume": 909320,
"dayLow": 60.96,
"dayHigh": 62.525,
"yearHigh": 88.31,
"yearLow": 54.3,
"marketCap": 7699914040,
"priceAvg50": 73.264,
"priceAvg200": 70.1524,
"exchange": "NASDAQ",
"open": 62.2,
"previousClose": 62.7,
"timestamp": 1791300912,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-25",
"v": 77.9226,
"c": 77.46
},
{
"t": "2026-08-26",
"v": 78.6557,
"c": 79.2
},
{
"t": "2026-08-27",
"v": 78.4827,
"c": 77.9
},
{
"t": "2026-08-28",
"v": 72.8008,
"c": 72.09
},
{
"t": "2026-08-31",
"v": 70.4305,
"c": 70.91
},
{
"t": "2026-09-01",
"v": 71.5279,
"c": 71.4
},
{
"t": "2026-09-02",
"v": 71.5864,
"c": 71.93
},
{
"t": "2026-09-03",
"v": 73.4948,
"c": 73.95
},
{
"t": "2026-09-04",
"v": 72.7972,
"c": 72.72
},
{
"t": "2026-09-08",
"v": 75.5036,
"c": 75.35
},
{
"t": "2026-09-09",
"v": 74.0053,
"c": 74.11
},
{
"t": "2026-09-10",
"v": 73.964,
"c": 73.62
},
{
"t": "2026-09-11",
"v": 74.3085,
"c": 73.77
},
{
"t": "2026-09-14",
"v": 73.2242,
"c": 72.45
},
{
"t": "2026-09-15",
"v": 69.4215,
"c": 69.31
},
{
"t": "2026-09-16",
"v": 69.5063,
"c": 69.39
},
{
"t": "2026-09-17",
"v": 69.8881,
"c": 69.92
},
{
"t": "2026-09-18",
"v": 68.8764,
"c": 68.78
},
{
"t": "2026-09-21",
"v": 67.7583,
"c": 67.56
},
{
"t": "2026-09-22",
"v": 68.0894,
"c": 67.59
},
{
"t": "2026-09-23",
"v": 65.6935,
"c": 65.81
},
{
"t": "2026-09-24",
"v": 65.6361,
"c": 65.66
},
{
"t": "2026-09-25",
"v": 64.8301,
"c": 64.66
},
{
"t": "2026-09-28",
"v": 65.6612,
"c": 66.16
},
{
"t": "2026-09-29",
"v": 65.0773,
"c": 65.64
},
{
"t": "2026-09-30",
"v": 66.0886,
"c": 65.91
},
{
"t": "2026-10-01",
"v": 65.9747,
"c": 65.62
},
{
"t": "2026-10-02",
"v": 65.2319,
"c": 65.6
},
{
"t": "2026-10-05",
"v": 63.2529,
"c": 62.7
},
{
"t": "2026-10-06",
"v": 61.6849,
"c": 61.94
}
],
"vwap_summary": {
"days": 30,
"days_above": 12,
"days_below": 18,
"pct_days_above": 40,
"position": "above",
"gap_pct": 0.41,
"streak_days": 1
}
}
Data:
{
"volume": 909320,
"avgVolume": 2048917,
"short_ratio": [
{
"symbol": "CYTK",
"file_date": "2026-10-05",
"date": "20261005",
"short_volume": 1017103,
"short_exempt_volume": 65,
"total_volume": 1484468,
"short_volume_ratio": 0.6852,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 64.83,
"vah": 69.12,
"val": 61.02,
"profile": [
{
"price": 61.14,
"volume": 189710
},
{
"price": 61.39,
"volume": 86869
},
{
"price": 61.63,
"volume": 159478
},
{
"price": 61.88,
"volume": 269336
},
{
"price": 62.13,
"volume": 195816
},
{
"price": 62.37,
"volume": 86618
},
{
"price": 62.62,
"volume": 373344
},
{
"price": 62.86,
"volume": 491958
},
{
"price": 63.11,
"volume": 125533
},
{
"price": 63.35,
"volume": 149281
},
{
"price": 63.6,
"volume": 372594
},
{
"price": 63.84,
"volume": 704627
},
{
"price": 64.09,
"volume": 135274
},
{
"price": 64.34,
"volume": 61006
},
{
"price": 64.58,
"volume": 1415580
},
{
"price": 64.83,
"volume": 2346574
},
{
"price": 65.07,
"volume": 1248168
},
{
"price": 65.32,
"volume": 1506142
},
{
"price": 65.56,
"volume": 1712493
},
{
"price": 65.81,
"volume": 1811906
},
{
"price": 66.05,
"volume": 1523015
},
{
"price": 66.3,
"volume": 1577968
},
{
"price": 66.55,
"volume": 425178
},
{
"price": 66.79,
"volume": 83034
},
{
"price": 67.04,
"volume": 68198
},
{
"price": 67.28,
"volume": 30268
},
{
"price": 67.53,
"volume": 752932
},
{
"price": 67.77,
"volume": 350037
},
{
"price": 68.02,
"volume": 451376
},
{
"price": 68.26,
"volume": 409677
},
{
"price": 68.51,
"volume": 364571
},
{
"price": 68.76,
"volume": 989156
},
{
"price": 69.0,
"volume": 670021
},
{
"price": 69.25,
"volume": 1409977
},
{
"price": 69.49,
"volume": 400802
},
{
"price": 69.74,
"volume": 679935
},
{
"price": 69.98,
"volume": 905752
},
{
"price": 70.23,
"volume": 550657
},
{
"price": 70.47,
"volume": 84753
},
{
"price": 70.72,
"volume": 38901
},
{
"price": 70.97,
"volume": 18845
},
{
"price": 71.21,
"volume": 0
},
{
"price": 71.46,
"volume": 0
},
{
"price": 71.7,
"volume": 32807
},
{
"price": 71.95,
"volume": 0
},
{
"price": 72.19,
"volume": 0
},
{
"price": 72.44,
"volume": 210456
},
{
"price": 72.69,
"volume": 101421
},
{
"price": 72.93,
"volume": 15746
},
{
"price": 73.18,
"volume": 64051
},
{
"price": 73.42,
"volume": 221304
},
{
"price": 73.67,
"volume": 1074663
},
{
"price": 73.91,
"volume": 855688
},
{
"price": 74.16,
"volume": 1272742
},
{
"price": 74.4,
"volume": 437816
},
{
"price": 74.65,
"volume": 231330
},
{
"price": 74.9,
"volume": 99402
},
{
"price": 75.14,
"volume": 13495
},
{
"price": 75.39,
"volume": 162402
},
{
"price": 75.63,
"volume": 92797
}
],
"sessions": 20
}
}
Data:
{
"symbol": "CYTK",
"marketCap": 7698669710,
"enterpriseValueTTM": 8713953710,
"evToSalesTTM": 122.80092601465614,
"evToOperatingCashFlowTTM": -15.688012713385314,
"evToFreeCashFlowTTM": -15.005559913220013,
"evToEBITDATTM": -10.644947117029073,
"netDebtToEBITDATTM": -1.2402687515269972,
"currentRatioTTM": 6.660936234008896,
"incomeQualityTTM": 0.6213106894615448,
"grahamNumberTTM": null,
"grahamNetNetTTM": -6.918507638962494,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1.0715015970611677,
"workingCapitalTTM": 1027058000,
"investedCapitalTTM": 1178870000,
"returnOnAssetsTTM": -0.46452497231821865,
"operatingReturnOnAssetsTTM": -0.4406595437377209,
"returnOnTangibleAssetsTTM": -0.46452497231821865,
"returnOnEquityTTM": 1.63976663641787,
"returnOnInvestedCapitalTTM": -0.39330859459163775,
"returnOnCapitalEmployedTTM": -0.4042293081035062,
"earningsYieldTTM": -0.10939603609024426,
"freeCashFlowYieldTTM": -0.07543056409416998,
"capexToOperatingCashFlowTTM": -0.045479995689068194,
"capexToDepreciationTTM": 2.0130687704199537,
"capexToRevenueTTM": 0.35600338218714767,
"salesGeneralAndAdministrativeToRevenueTTM": 5.220885005636979,
"researchAndDevelopementToRevenueTTM": 5.553861330326945,
"stockBasedCompensationToRevenueTTM": 1.364162908680947,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 15629500,
"averagePayablesTTM": 22609500,
"averageInventoryTTM": 267000,
"daysOfSalesOutstandingTTM": 125.6719278466742,
"daysOfPayablesOutstandingTTM": 702.0678983400544,
"daysOfInventoryOutstandingTTM": 13.00759636124918,
"operatingCycleTTM": 138.67952420792338,
"cashConversionCycleTTM": -563.388374132131,
"freeCashFlowToEquityTTM": -90514999,
"freeCashFlowToFirmTTM": -455891999,
"tangibleAssetValueTTM": -173487000,
"netCurrentAssetValueTTM": -889551000,
"grossProfitMarginTTM": 0.8497322435174747,
"ebitMarginTTM": -11.757962232243518,
"ebitdaMarginTTM": -11.53607666290868,
"operatingProfitMarginTTM": -9.929833709131906,
"pretaxProfitMarginTTM": -12.598675310033823,
"continuousOperationsProfitMarginTTM": -12.598675310033823,
"netProfitMarginTTM": -12.598675310033823,
"bottomLineProfitMarginTTM": -12.598675310033823,
"receivablesTurnoverTTM": 2.9043876882776685,
"payablesTurnoverTTM": 0.519892735251097,
"inventoryTurnoverTTM": 28.060526315789474,
"fixedAssetTurnoverTTM": 0.467420230284826,
"assetTurnoverTTM": 0.036870937688842746,
"quickRatioTTM": 6.658841750767518,
"solvencyRatioTTM": -0.4186087191938373,
"cashRatioTTM": 1.4070021881838075,
"priceToEarningsRatioTTM": -8.581137309292648,
"priceToEarningsGrowthRatioTTM": 0.2568459694703268,
"forwardPriceToEarningsGrowthRatioTTM": 1.2714036477634298,
"priceToEarningsDilutedRatioTTM": -8.569252077562327,
"priceToEarningsDilutedGrowthRatioTTM": 0.2557346139948394,
"priceToBookRatioTTM": -47.10532097505865,
"priceToSalesRatioTTM": 108.49309061443066,
"priceToFreeCashFlowRatioTTM": -13.257225529316836,
"priceToOperatingCashFlowRatioTTM": -14.712605449448656,
"debtToAssetsRatioTTM": 0.6601825568665107,
"debtToEquityRatioTTM": -7.323632318271686,
"debtToCapitalRatioTTM": 1.1581369614280974,
"longTermDebtToCapitalRatioTTM": 1.1833431616859111,
"financialLeverageRatioTTM": -11.093344169880163,
"workingCapitalTurnoverRatioTTM": 0.08511771458456534,
"operatingCashFlowRatioTTM": -3.0615447309966983,
"operatingCashFlowSalesRatioTTM": -7.827691643179256,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0454799956890681,
"debtServiceCoverageRatioTTM": -5.379120915225948,
"interestCoverageRatioTTM": -5.644961265151454,
"shortTermOperatingCashFlowCoverageRatioTTM": -20.30312884713795,
"operatingCashFlowCoverageRatioTTM": -0.437173517872111,
"capitalExpenditureCoverageRatioTTM": -21.987688979494894,
"dividendPaidAndCapexCoverageRatioTTM": -21.987688979494894,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0.5372257468618931,
"netIncomePerShareTTM": -6.768332752903412,
"interestDebtPerShareTTM": 10.564162742455673,
"cashPerShareTTM": 8.825204790818104,
"bookValuePerShareTTM": -1.3134397286616295,
"tangibleBookValuePerShareTTM": -1.3134397286616295,
"shareholdersEquityPerShareTTM": -1.3134397286616295,
"operatingCashFlowPerShareTTM": -4.205237489211575,
"capexPerShareTTM": 0.19125418288085036,
"freeCashFlowPerShareTTM": -4.3964916720924245,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 1.2687700196275729,
"priceToFairValueTTM": -47.10532097505865,
"debtToMarketCapTTM": 0.14899807930583372,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -10.644947117029073,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 88039000
}
],
"dcf": {
"symbol": "CYTK",
"date": "2026-10-06",
"dcf": -60.3519116190948,
"Stock Price": 62.7
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "CYTK",
"reportedCurrency": "USD",
"cik": "0001061983",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 16:01:01",
"fiscalYear": "2025",
"period": "FY",
"revenue": 88039000,
"costOfRevenue": 10125000,
"grossProfit": 77914000,
"researchAndDevelopmentExpenses": 405901000,
"generalAndAdministrativeExpenses": 284271000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 284271000,
"otherExpenses": 0,
"operatingExpenses": 690172000,
"costAndExpenses": 700297000,
"netInterestIncome": -55448000,
"interestIncome": 48420000,
"interestExpense": 103868000,
"depreciationAndAmortization": 9685331,
"ebitda": -775269669,
"ebit": -784955000,
"nonOperatingIncomeExcludingInterest": 172697000,
"operatingIncome": -612258000,
"totalOtherIncomeExpensesNet": -172697000,
"incomeBeforeTax": -784955000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -784955000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -784955000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -784955000,
"eps": -6.54,
"epsDiluted": -6.54,
"weightedAverageShsOut": 120023700,
"weightedAverageShsOutDil": 120103000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "CYTK",
"reportedCurrency": "USD",
"cik": "0001061983",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 16:01:01",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 122518000,
"shortTermInvestments": 759703000,
"cashAndShortTermInvestments": 882221000,
"netReceivables": 17764000,
"accountsReceivables": 17764000,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 16990000,
"totalCurrentAssets": 916975000,
"propertyPlantEquipmentNet": 155173000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 335048000,
"taxAssets": 0,
"otherNonCurrentAssets": 17341000,
"totalNonCurrentAssets": 507562000,
"otherAssets": 0,
"totalAssets": 1424537000,
"totalPayables": 22337000,
"accountPayables": 22337000,
"otherPayables": 0,
"accruedExpenses": 38128000,
"shortTermDebt": 41181000,
"capitalLeaseObligationsCurrent": 19111000,
"taxPayables": 0,
"deferredRevenue": 1612000,
"otherCurrentLiabilities": 80083000,
"totalCurrentLiabilities": 202452000,
"longTermDebt": 1115981000,
"capitalLeaseObligationsNonCurrent": 107970000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 657759000,
"totalNonCurrentLiabilities": 1881710000,
"otherLiabilities": 0,
"capitalLeaseObligations": 127081000,
"totalLiabilities": 2084162000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 123000,
"retainedEarnings": -3486719000,
"additionalPaidInCapital": 2826341000,
"accumulatedOtherComprehensiveIncomeLoss": 630000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": -659625000,
"totalEquity": -659625000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 1424537000,
"totalInvestments": 1094751000,
"totalDebt": 1284243000,
"netDebt": 1161725000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "CYTK",
"reportedCurrency": "USD",
"cik": "0001061983",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 16:01:01",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -784955000,
"depreciationAndAmortization": 10125000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 112286000,
"changeInWorkingCapital": -35628000,
"accountsReceivables": -1114000,
"inventory": 0,
"accountsPayables": 2663000,
"otherWorkingCapital": -37177000,
"otherNonCashItems": 188163000,
"netCashProvidedByOperatingActivities": -510009000,
"investmentsInPropertyPlantAndEquipment": -24807000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -1063173000,
"salesMaturitiesOfInvestments": 1109646000,
"otherInvestingActivities": -5000000,
"netCashProvidedByInvestingActivities": 16666000,
"netDebtIssuance": 490947000,
"longTermNetDebtIssuance": 490947000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 35979000,
"netCommonStockIssuance": 35979000,
"commonStockIssuance": 35979000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -2468000,
"netCashProvidedByFinancingActivities": 524458000,
"effectOfForexChangesOnCash": -714999,
"netChangeInCash": 30400000,
"cashAtEndOfPeriod": 125632000,
"cashAtBeginningOfPeriod": 95232000,
"operatingCashFlow": -510009000,
"capitalExpenditure": -24807000,
"freeCashFlow": -534816000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 61.9366,
"rsi": 25.510698604368542,
"sma20": 67.80982999999993,
"sma50": 72.89033200000003,
"sma200": 70.162983,
"adx": 28.318952659300642,
"atr": 2.14,
"atr_pct": 3.46,
"atr_expansion_pct": -14.6,
"di_plus": 5.9,
"di_minus": 30.4,
"high_52w": 87.26,
"low_52w": 47.83,
"structure": {
"ema8": 64.63400444136899,
"ema21": 67.54146526434899,
"ema50": 71.30076343685664,
"ema200": 69.28369960537967,
"ema10": 65.12949029268444,
"ema20": 67.34525200911321,
"ema10_slope_pct": -3.13,
"ema20_slope_pct": -3.0,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": false,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -8.3,
"_no_bars": false,
"macd": {
"macd": -2.849,
"signal": -2.603,
"histogram": -0.247
},
"bollinger": {
"mid": 67.81,
"upper": 74.75,
"lower": 60.87,
"width_pct": 20.46
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -8.4,
"ret_3d": -5.61,
"ret_5d": -5.64,
"roc10_accel": -3.07,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.42,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -1.48,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": false
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 126766494.78999999
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.1,
"iv_rank": 9.0
}
}
}
}
Data:
{
"prior_day": {
"high": 62.52,
"low": 60.96,
"close": 61.94,
"date": "2026-10-06"
},
"woodie_pivots": {
"PP": 61.84,
"R1": 62.72,
"S1": 61.16,
"R2": 63.41,
"S2": 60.28
},
"swing": {
"high_20d": 75.98,
"low_20d": 60.96,
"high_60d": 83.83,
"low_60d": 60.96
},
"orb": {
"high": 62.52,
"low": 61.63,
"date": "2026-10-06"
},
"vwap": 61.68,
"volume_profile": {
"poc": 64.83,
"vah": 69.12,
"val": 61.02,
"sessions": 20
},
"intraday": {
"h1_trend": "down",
"h1_last": 61.68,
"h1_ema9": 62.85,
"h1_ema21": 63.92,
"m15_trend": "flat",
"m15_last": 61.94,
"m15_ema9": 61.86,
"m15_ema21": 62.39,
"rvol_intraday": 1.64,
"as_of_et": "2026-10-06 11:30"
},
"premarket": {
"date": "2026-10-06",
"high": 63.9,
"low": 62.5,
"last": 62.5,
"volume": 4544,
"gap_pct": -0.32,
"path": "04:50 63.90 -> 08:40 63.00 -> 09:20 62.95 -> 09:25 62.50",
"bars": 4,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-09-01",
"o": 69.85,
"h": 72.455,
"l": 69.83,
"c": 71.4,
"v": 1899653.335526
},
{
"d": "2026-09-02",
"o": 71.9,
"h": 73.7,
"l": 70.42,
"c": 71.93,
"v": 1605679.730772
},
{
"d": "2026-09-03",
"o": 73.55,
"h": 74.225,
"l": 71.41,
"c": 73.95,
"v": 1589734.366211
},
{
"d": "2026-09-04",
"o": 73.04,
"h": 74.01,
"l": 72.255,
"c": 72.72,
"v": 1140923.030965
},
{
"d": "2026-09-08",
"o": 72.39,
"h": 76.805,
"l": 72.39,
"c": 75.35,
"v": 1921008.126364
},
{
"d": "2026-09-09",
"o": 74.31,
"h": 74.89,
"l": 73.52,
"c": 74.11,
"v": 1424847.543391
},
{
"d": "2026-09-10",
"o": 73.23,
"h": 75.1,
"l": 73.13,
"c": 73.62,
"v": 1444873.412574
},
{
"d": "2026-09-11",
"o": 74.66,
"h": 75.98,
"l": 73.5,
"c": 73.77,
"v": 1721518.814257
},
{
"d": "2026-09-14",
"o": 73.505,
"h": 74.65,
"l": 72.34,
"c": 72.45,
"v": 1533560.40552
},
{
"d": "2026-09-15",
"o": 72.13,
"h": 72.19,
"l": 68.55,
"c": 69.31,
"v": 2576731.907022
},
{
"d": "2026-09-16",
"o": 69.52,
"h": 70.68,
"l": 68.67,
"c": 69.39,
"v": 2211795.583774
},
{
"d": "2026-09-17",
"o": 70.64,
"h": 71.05,
"l": 68.915,
"c": 69.92,
"v": 1398170.1712
},
{
"d": "2026-09-18",
"o": 70.18,
"h": 70.18,
"l": 68.15,
"c": 68.78,
"v": 4872972.842106
},
{
"d": "2026-09-21",
"o": 69.3,
"h": 69.495,
"l": 67.35,
"c": 67.56,
"v": 1603484.634266
},
{
"d": "2026-09-22",
"o": 68.07,
"h": 69.56,
"l": 67.48,
"c": 67.59,
"v": 2388591.215984
},
{
"d": "2026-09-23",
"o": 67.02,
"h": 67.385,
"l": 64.725,
"c": 65.81,
"v": 2050950.855244
},
{
"d": "2026-09-24",
"o": 65.37,
"h": 66.47,
"l": 64.89,
"c": 65.66,
"v": 1836856.868781
},
{
"d": "2026-09-25",
"o": 65.66,
"h": 65.945,
"l": 64.44,
"c": 64.66,
"v": 1599221.633212
},
{
"d": "2026-09-28",
"o": 64.58,
"h": 66.41,
"l": 64.25,
"c": 66.16,
"v": 2551193.803045
},
{
"d": "2026-09-29",
"o": 65.91,
"h": 66.52,
"l": 64.38,
"c": 65.64,
"v": 2401772.382395
},
{
"d": "2026-09-30",
"o": 65.9,
"h": 66.92,
"l": 65.25,
"c": 65.91,
"v": 2977682.342623
},
{
"d": "2026-10-01",
"o": 65.73,
"h": 67.27,
"l": 65.3,
"c": 65.62,
"v": 1724383.083772
},
{
"d": "2026-10-02",
"o": 66.45,
"h": 66.91,
"l": 64.49,
"c": 65.6,
"v": 2649872.47502
},
{
"d": "2026-10-05",
"o": 65.6,
"h": 65.755,
"l": 62.19,
"c": 62.7,
"v": 3234412.456866
},
{
"d": "2026-10-06",
"o": 62.2,
"h": 62.525,
"l": 60.96,
"c": 61.94,
"v": 906341.772709
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "mixed",
"etf_r5d": -2.27,
"etf_rvol": 0.9,
"rs_5d": -2.96,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "CYTK",
"date": "2030-12-31",
"revenueLow": 1760798644,
"revenueHigh": 3135656007,
"revenueAvg": 2286158778,
"ebitdaLow": 755173604,
"ebitdaHigh": 1212025656,
"ebitdaAvg": 929745597,
"ebitLow": 492472585,
"ebitHigh": 949324637,
"ebitAvg": 667044578,
"netIncomeLow": 323734036,
"netIncomeHigh": 684647157,
"netIncomeAvg": 461645910,
"sgaExpenseLow": 14507585071,
"sgaExpenseHigh": 25835319916,
"sgaExpenseAvg": 18836136131,
"epsAvg": 3.84375,
"epsHigh": 5.7005,
"epsLow": 2.69547,
"numAnalystsRevenue": 14,
"numAnalystsEps": 11
},
{
"symbol": "CYTK",
"date": "2029-12-31",
"revenueLow": 1159903775,
"revenueHigh": 2065573625,
"revenueAvg": 1505978100,
"ebitdaLow": 308161651,
"ebitdaHigh": 383964887,
"ebitdaAvg": 337127757,
"ebitLow": 150677688,
"ebitHigh": 226480924,
"ebitAvg": 179643794,
"netIncomeLow": 53716067,
"netIncomeHigh": 113600624,
"netIncomeAvg": 76599291,
"sgaExpenseLow": 9556687670,
"sgaExpenseHigh": 17018689325,
"sgaExpenseAvg": 12408065780,
"epsAvg": 0.63778,
"epsHigh": 0.94586,
"epsLow": 0.44725,
"numAnalystsRevenue": 14,
"numAnalystsEps": 7
},
{
"symbol": "CYTK",
"date": "2028-12-31",
"revenueLow": 701763831,
"revenueHigh": 1197213548,
"revenueAvg": 891726478,
"ebitdaLow": -320563627,
"ebitdaHigh": 140528606,
"ebitdaAvg": -120485311,
"ebitLow": -404845439,
"ebitHigh": 56246795,
"ebitAvg": -204767123,
"netIncomeLow": -487528106,
"netIncomeHigh": -26435871,
"netIncomeAvg": -287449790,
"sgaExpenseLow": 5781977691,
"sgaExpenseHigh": 9864090624,
"sgaExpenseAvg": 7347119322,
"epsAvg": -2.10946,
"epsHigh": -0.22011,
"epsLow": -4.05925,
"numAnalystsRevenue": 16,
"numAnalystsEps": 14
},
{
"symbol": "CYTK",
"date": "2027-12-31",
"revenueLow": 323354535,
"revenueHigh": 572416877,
"revenueAvg": 423594441,
"ebitdaLow": -524401803,
"ebitdaHigh": -242541678,
"ebitdaAvg": -507575219,
"ebitLow": -563096757,
"ebitHigh": -281236632,
"ebitAvg": -546270173,
"netIncomeLow": -645779424,
"netIncomeHigh": -363919299,
"netIncomeAvg": -628952840,
"sgaExpenseLow": 2664185050,
"sgaExpenseHigh": 4716261321,
"sgaExpenseAvg": 3490082417,
"epsAvg": -4.47578,
"epsHigh": -3.03006,
"epsLow": -5.37688,
"numAnalystsRevenue": 16,
"numAnalystsEps": 15
}
],
"price_target": {
"symbol": "CYTK",
"targetHigh": 140,
"targetLow": 95,
"targetConsensus": 112.5,
"targetMedian": 112
},
"ratings": {
"symbol": "CYTK",
"rating": "C",
"overallScore": 2,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 1,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "CYTK",
"date": "2026-08-31",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-13",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-13",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-10",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-07",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-08-07",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-06-29",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "CYTK",
"date": "2026-06-24",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-06-17",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-12",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-11",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-07",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-06",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-06",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-06",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-05-05",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-04-06",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-03-18",
"gradingCompany": "Mizuho",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-03-17",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-03-06",
"gradingCompany": "UBS",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-02-26",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-02-25",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-02-25",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-02-20",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-02-03",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-01-21",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-01-21",
"gradingCompany": "B. Riley Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2026-01-20",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-23",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-22",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-22",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-22",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-22",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-22",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-12-19",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "CYTK",
"date": "2025-12-12",
"gradingCompany": "Needham",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-11-11",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-11-10",
"gradingCompany": "B. Riley Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "CYTK",
"date": "2025-10-06",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026",
"url": "https://www.globenewswire.com/news-release/2026/10/02/3373753/35409/en/cytokinetics-announces-four-upcoming-presentations-at-the-hfsa-annual-scientific-meeting-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-02T11:30:00Z",
"summary": "Cytokinetics announced four presentations at the Heart Failure Society of America Annual Scientific Meeting in October 2026, including two late-breaking clinical research presentations on aficamten (MYQORZO) for hypertrophic cardiomyopathy. The company plans to submit a Supplemen",
"image": "https://ml.globenewswire.com/Resource/Download/52e2be9f-e9e3-43af-a747-123fdcac4253"
},
{
"title": "Cytokinetics launches real-world study of heart drug MYQORZO By Investing.com",
"url": "https://www.investing.com/news/company-news/cytokinetics-launches-realworld-study-of-heart-drug-myqorzo-93CH-4924897",
"source": "Investing.com",
"date": "2026-09-30T11:36:31Z",
"summary": "SOUTH SAN FRANCISCO - Cytokinetics, Incorporated (NASDAQ:CYTK) announced today the launch of ASPEN-HCM, a prospective, multicenter observational study evaluating MYQORZO (aficamten) in adult patients with symptomatic obstructive hypertrophic cardiomyopathy, according to a press r",
"image": "https://content-media.investing.com/news/LYNXMPEM1P0JL_1200_L.jpg"
},
{
"title": "Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO\u00ae (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy",
"url": "https://www.globenewswire.com/news-release/2026/09/30/3371784/35409/en/cytokinetics-launches-aspen-hcm-a-real-world-study-evaluating-myqorzo-aficamten-in-symptomatic-obstructive-hypertrophic-cardiomyopathy.html",
"source": "GlobeNewsWire",
"date": "2026-09-30 07:30:00",
"summary": "Multi-center Prospective Study to Track Real-World Safety, Clinical Effectiveness, and Healthcare Resource Impact of MYQORZO in Routine Clinical Practice",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-launches-aspenhcm-a-realworld-study-evaluating-myqorzo-aficamten-20260930.jpg"
},
{
"title": "Cytokinetics CEO Robert Blum sells $490,949 in stock By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/cytokinetics-ceo-robert-blum-sells-490949-in-stock-93CH-4921663",
"source": "Investing.com",
"date": "2026-09-29T07:01:14Z",
"summary": "Robert I. Blum, President and Chief Executive Officer of Cytokinetics Inc. (NASDAQ:CYTK), sold common stock totaling $490,949 on September 28, 2026, according to a recent SEC filing. Mr. Blum also serves as a Director of the company.\n\nThe transaction involved the disposition of 7",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM431A2_1200_L.jpg"
},
{
"title": "B. Riley's Top Biotech Picks Ahead of 3Q26 Earnings Season By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/b-rileys-top-biotech-picks-ahead-of-3q26-earnings-season-4917781",
"source": "Investing.com",
"date": "2026-09-25T15:09:48Z",
"summary": "Investing.com -- B. Riley analyst Mayank Mamtani has identified top biotech picks heading into third-quarter 2026 earnings season, following the Federal Reserve's 25 basis point rate hike to 4.00%, its first increase since July 2023. The unanimous 12-0 vote left room for one to t",
"image": "https://content-media.investing.com/news/LYNXMPEM5H10K_1200_L.jpg"
},
{
"title": "Cytokinetics Maps MYQORZO Expansion, Heart Failure Pipeline at Bernstein Conference",
"url": "https://www.marketbeat.com/instant-alerts/event-cytokinetics-maps-myqorzo-expansion-heart-failure-pipeline-at-bernstein-conference-2026-09-25/",
"source": "MarketBeat",
"date": "2026-09-25 10:02:37",
"summary": "Cytokinetics NASDAQ: CYTK executives outlined the company's commercial expansion plans, cardiovascular pipeline and business-development priorities during a Bernstein investor symposium, highlighting the launch of MYQORZO and clinical programs targeting several forms of heart fai",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-maps-myqorzo-expansion-heart-failure-pipeline-at-bernstein-20260925.jpg"
},
{
"title": "Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/09/24/bristol-myers-squibb-vs-pfizer-which-healthcare-stock-is-a-better-buy-in-2026/",
"source": "Fool - Investing News",
"date": "2026-09-24 07:56:09",
"summary": "Both face patent cliffs and pay generous dividends, but only one of them can tell you where its next wave of growth is coming from.",
"image": "https://images.financialmodelingprep.com/news/bristol-myers-squibb-vs-pfizer-which-healthcare-stock-is-20260924.jpg"
},
{
"title": "Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?",
"url": "https://finance.yahoo.com/healthcare/articles/cytokinetics-cytk-myqorzo-growth-create-132125710.html",
"source": "Yahoo! Finance",
"date": "2026-09-23T13:21:25Z",
"summary": "Polaris Capital Management, an investment management company, released its second-quarter 2026 investor letter for \"Global Equity Strategy\". The letter can be downloaded here. Global markets delivered strong gains during the quarter, supported by an AI-driven earnings rally despi",
"image": "https://s.yimg.com/lo/mysterio/api/c38c2a06ddd824afd7bdc81d3bed49d6ff779c66a0a5f9461581f14f6db9a7ef/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2Ffc902f1ba26df5db1c41db4e73a60ad5.jpg"
},
{
"title": "Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 3,500 Shares of Stock",
"url": "https://www.defenseworld.net/2026/09/23/cytokinetics-nasdaqcytk-evp-fady-ibraham-malik-sells-3500-shares-of-stock.html",
"source": "Defense World",
"date": "2026-09-23 05:12:18",
"summary": "Cytokinetics, Incorporated (NASDAQ: CYTK - Get Free Report) EVP Fady Malik sold 3,500 shares of the firm's stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $68.29, for a total value of $239,015.00. Following the transaction, the execu",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-nasdaqcytk-evp-fady-ibraham-malik-sells-3500-shares-20260923.png"
},
{
"title": "Cytokinetics EVP Fady Malik sells $239k in company stock By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/cytokinetics-evp-fady-malik-sells-239k-in-company-stock-93CH-4911806",
"source": "Investing.com",
"date": "2026-09-22T22:45:57Z",
"summary": "Fady Ibraham Malik, Executive Vice President of Research & Development at Cytokinetics Inc. (NASDAQ:CYTK), sold company common stock totaling $239,015 on September 22, 2026.\n\nAccording to a recent filing, Malik disposed of 3,500 shares of Cytokinetics common stock at a price of $",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg"
},
{
"title": "AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/09/18/abbvie-vs-bristol-myers-squibb-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-09-18T13:15:01Z",
"summary": "AbbVie and Bristol Myers Squibb are compared as pharmaceutical investment options for 2026. AbbVie is recommended as the better buy due to its successful immunology franchise with Skyrizi and Rinvoq driving growth, diversification into aesthetics and neuroscience, and having navi",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F93f4fcd8f1072083ee446c545b2c796e8edc7e8a-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Robert Blum Sells 97,926 Shares of Cytokinetics (NASDAQ:CYTK) Stock",
"url": "https://www.defenseworld.net/2026/09/17/robert-blum-sells-97926-shares-of-cytokinetics-nasdaqcytk-stock.html",
"source": "Defense World",
"date": "2026-09-17 04:11:26",
"summary": "Cytokinetics, Incorporated (NASDAQ: CYTK - Get Free Report) CEO Robert Blum sold 97,926 shares of Cytokinetics stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $69.33, for a total value of $6,789,209.58. Following the tr",
"image": "https://images.financialmodelingprep.com/news/robert-blum-sells-97926-shares-of-cytokinetics-nasdaqcytk-stock-20260917.png"
},
{
"title": "Cytokinetics CEO Blum's trust sells $6.7m in company shares By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/cytokinetics-ceo-blums-trust-sells-67m-in-company-shares-93CH-4903045",
"source": "Investing.com",
"date": "2026-09-16T08:16:13Z",
"summary": "Robert I. Blum, President and CEO of Cytokinetics Inc. (NASDAQ:CYTK), and a trust associated with him, recently reported significant share transactions. A trust linked to Mr. Blum sold 97,926 shares of common stock for approximately $6.79 million, with shares trading at $69.33. S",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
},
{
"title": "Cytokinetics, Incorporated (CYTK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946013-cytokinetics-incorporated-cytk-presents-at-morgan-stanley-24th-annual-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-14 10:31:49",
"summary": "Cytokinetics, Incorporated (CYTK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-incorporated-cytk-presents-at-morgan-stanley-24th-annual-20260914.jpg"
},
{
"title": "Cytokinetics: Why Myqorzo Doesn't Make Me A Buyer Yet",
"url": "https://seekingalpha.com/article/4945983-cytokinetics-why-myqorzo-doesnt-make-me-a-buyer-yet",
"source": "Seeking Alpha",
"date": "2026-09-14 09:07:35",
"summary": "Cytokinetics, Incorporated's stock remains under pressure. At the same time, Myqorzo sales rose 427.1% quarter-over-quarter to $25.3 million in the second quarter, despite competitive pressure from Bristol Myers Squibb's Camzyos. Meanwhile, the August 28 NEJM article revealed ful",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-why-myqorzo-doesnt-make-me-a-buyer-yet-20260914.jpg"
},
{
"title": "Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program",
"url": "https://www.globenewswire.com/news-release/2026/09/14/3360982/35409/en/cytokinetics-announces-call-for-proposals-for-ninth-annual-communications-grant-program.html",
"source": "GlobeNewsWire",
"date": "2026-09-14 07:30:00",
"summary": "Program Provides Communications and Outreach Support for Patient Advocacy Organizations Focused on Cardiovascular Diseases",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-announces-call-for-proposals-for-ninth-annual-communications-20260914.jpg"
},
{
"title": "Cytokinetics director Robert Landry sells $74,660 in shares By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/cytokinetics-director-robert-landry-sells-74660-in-shares-93CH-4898575",
"source": "Investing.com",
"date": "2026-09-12T00:15:55Z",
"summary": "Robert E. Landry, a director at Cytokinetics Inc. (NASDAQ:CYTK), sold 1,000 shares of the company's common stock on September 11, 2026. The transaction totaled $74,660, with shares sold at a price of $74.66 each.\n\nFollowing this sale, Mr. Landry directly holds 9,184 shares of Cyt",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
},
{
"title": "Cantor Fitzgerald reiterates Overweight on Cytokinetics stock By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-overweight-on-cytokinetics-stock-93CH-4897841",
"source": "Investing.com",
"date": "2026-09-11T12:14:48Z",
"summary": "Investing.com - Cantor Fitzgerald reiterated an Overweight rating on Cytokinetics (NASDAQ:CYTK). The firm provided an update on the company's commercial and regulatory outlook. The stock has delivered a 38% return over the past year, trading at $73.62 with a market cap of $10.23 ",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
},
{
"title": "Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com",
"url": "https://www.investing.com/news/transcripts/cytokinetics-at-citigroup-summit-hcm-expansion-drives-growth-hopes-93CH-4894417",
"source": "Investing.com",
"date": "2026-09-09T19:56:35Z",
"summary": "On Wednesday, 09 September 2026, Cytokinetics (CYTK) used Citigroup's Biopharma Back to School Summit 2026 to outline a broader growth story built around its heart drug MYQORZO. Management pointed to strong launch momentum in obstructive hypertrophic cardiomyopathy, or OHCM, and ",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM431A2_1200_L.jpg"
},
{
"title": "Cytokinetics, Incorporated (CYTK) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"url": "https://seekingalpha.com/article/4944706-cytokinetics-incorporated-cytk-presents-at-citigroups-biopharma-back-to-school-summit-2026",
"source": "Seeking Alpha",
"date": "2026-09-09 17:47:33",
"summary": "Cytokinetics, Incorporated (CYTK) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/cytokinetics-incorporated-cytk-presents-at-citigroups-biopharma-back-to-20260909.jpg"
},
{
"title": "Could Aficamten Give Cytokinetics the First Approved nHCM Treatment?",
"url": "https://finance.yahoo.com/healthcare/articles/could-aficamten-cytokinetics-first-approved-010503950.html",
"source": "Yahoo! Finance",
"date": "2026-09-08T01:05:03Z",
"summary": "Cytokinetics, Incorporated (NASDAQ:CYTK) has reported detailed late-stage results that could support an expansion of aficamten into a form of genetic heart disease that currently does not have any approved treatments.\n\nAficamten is already approved under the brand name Myqorzo fo",
"image": "https://s.yimg.com/lo/mysterio/api/f25af7e4d11c3b77711e4dfc47c2a13b3bd8d872feaf8920ecd50ea36b06bd45/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F5348e66e2702f72d99a644e7ea290dc2.jpg"
},
{
"title": "Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook?",
"url": "https://www.zacks.com/stock/news/2985466/will-camzyos-long-term-benefits-strengthen-bmy-s-growth-outlook?cid=CS-ZC-FT-analyst_blog|quick_take-2985466",
"source": "Zacks Investment Research",
"date": "2026-09-04T19:36:00Z",
"summary": "Bristol Myers Squibb's Camzyos demonstrated durable reductions in LVOT obstruction over five years with 97.4% of patients achieving target gradients. Sales surged 74% year-over-year to $729 million in H1 2026. The company seeks FDA approval for adolescents with a decision expecte",
"image": "https://staticx-tuner.zacks.com/images/articles/main/b7/2106.jpg"
},
{
"title": "Cytokinetics to Participate in September Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/09/02/3355472/35409/en/cytokinetics-to-participate-in-september-investor-conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-02T20:00:00Z",
"summary": "Cytokinetics announced that management will participate in multiple investor conferences in September 2026. The company highlighted positive results from its ACACIA-HCM Phase 3 clinical trial for aficamten in non-obstructive hypertrophic cardiomyopathy (nHCM), with plans to submi",
"image": "https://ml.globenewswire.com/Resource/Download/52e2be9f-e9e3-43af-a747-123fdcac4253"
},
{
"title": "Can CYTK's Aficamten Strengthen Its HCM Growth Prospects?",
"url": "https://www.zacks.com/stock/news/2984032/can-cytk-s-aficamten-strengthen-its-hcm-growth-prospects?cid=CS-ZC-FT-analyst_blog|quick_take-2984032",
"source": "Zacks Investment Research",
"date": "2026-09-02T18:30:00Z",
"summary": "Cytokinetics announced additional positive results from ACACIA-HCM and MAPLE-HCM studies showing aficamten improved cardiac structure and diastolic function in non-obstructive HCM patients, and outperformed metoprolol in obstructive HCM. The company plans to file for nHCM approva",
"image": "https://staticx-tuner.zacks.com/images/articles/main/c9/106417.jpg"
},
{
"title": "Truist reiterates Buy on Cytokinetics stock, $112 target on HCM potential By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/truist-reiterates-buy-on-cytokinetics-stock-112-target-on-hcm-potential-93CH-4883632",
"source": "Investing.com",
"date": "2026-09-01T08:46:55Z",
"summary": "Investing.com - Truist Securities reiterated a Buy rating and $112.00 price target on Cytokinetics (NASDAQ:CYTK) shares following detailed ACACIA analyses presented at ESC this past weekend. The stock currently trades at $70.91, up over 100% in the past year, with analyst consens",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
}
]
Data:
[
{
"symbol": "CYTK",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": -1.45,
"revenueActual": null,
"revenueEstimated": 39883470,
"lastUpdated": "2026-10-06"
},
{
"symbol": "CYTK",
"date": "2026-08-06",
"epsActual": -1.5,
"epsEstimated": -1.63,
"revenueActual": 28624000,
"revenueEstimated": 17588120,
"lastUpdated": "2026-10-06"
},
{
"symbol": "CYTK",
"date": "2026-05-05",
"epsActual": -1.67,
"epsEstimated": -1.67,
"revenueActual": 19355000,
"revenueEstimated": 8518439,
"lastUpdated": "2026-08-05"
},
{
"symbol": "CYTK",
"date": "2026-02-24",
"epsActual": -1.5,
"epsEstimated": -1.48,
"revenueActual": 17755000,
"revenueEstimated": 6926249,
"lastUpdated": "2026-05-24"
},
{
"symbol": "CYTK",
"date": "2025-11-05",
"epsActual": -2.55,
"epsEstimated": -1.59,
"revenueActual": 1936000,
"revenueEstimated": 6049541,
"lastUpdated": "2026-08-17"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "CYTK",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "CYTK",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 19989,
"price": 87.26
},
{
"file_period": "202607a",
"settlement_date": "20260707",
"quantity_fails": 29,
"price": 85.57
},
{
"file_period": "202607b",
"settlement_date": "20260723",
"quantity_fails": 341,
"price": 82.19
},
{
"file_period": "202608a",
"settlement_date": "20260812",
"quantity_fails": 10465,
"price": 76.45
},
{
"file_period": "202608b",
"settlement_date": "20260831",
"quantity_fails": 202,
"price": 72.09
},
{
"file_period": "202609a",
"settlement_date": "20260914",
"quantity_fails": 98000,
"price": 73.77
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "CYTK",
"filingDate": "2026-09-28",
"transactionDate": "2026-09-28",
"reportingCik": "0001288859",
"companyCik": "0001061983",
"transactionType": "M-Exempt",
"securitiesOwned": 286044,
"reportingName": "Blum Robert I",
"typeOfOwner": "director, officer: President & CEO",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7500,
"price": 10.6,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000097/0001061983-26-000097-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-28",
"transactionDate": "2026-09-28",
"reportingCik": "0001288859",
"companyCik": "0001061983",
"transactionType": "S-Sale",
"securitiesOwned": 278544,
"reportingName": "Blum Robert I",
"typeOfOwner": "director, officer: President & CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7500,
"price": 65.46,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000097/0001061983-26-000097-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-28",
"transactionDate": "2026-09-28",
"reportingCik": "0001288859",
"companyCik": "0001061983",
"transactionType": "M-Exempt",
"securitiesOwned": 149245,
"reportingName": "Blum Robert I",
"typeOfOwner": "director, officer: President & CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7500,
"price": 10.6,
"securityName": "Non-Qualified Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000097/0001061983-26-000097-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-22",
"reportingCik": "0001551778",
"companyCik": "0001061983",
"transactionType": "M-Exempt",
"securitiesOwned": 157402,
"reportingName": "Malik Fady Ibraham",
"typeOfOwner": "officer: EVP Research & Development",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3500,
"price": 7.8,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000096/0001061983-26-000096-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-22",
"reportingCik": "0001551778",
"companyCik": "0001061983",
"transactionType": "S-Sale",
"securitiesOwned": 153902,
"reportingName": "Malik Fady Ibraham",
"typeOfOwner": "officer: EVP Research & Development",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3500,
"price": 68.29,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000096/0001061983-26-000096-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-22",
"reportingCik": "0001551778",
"companyCik": "0001061983",
"transactionType": "M-Exempt",
"securitiesOwned": 23386,
"reportingName": "Malik Fady Ibraham",
"typeOfOwner": "officer: EVP Research & Development",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3500,
"price": 7.8,
"securityName": "Non-Qualified Stock Option (Right to Buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000096/0001061983-26-000096-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-15",
"transactionDate": "2026-09-15",
"reportingCik": "0001585160",
"companyCik": "0001061983",
"transactionType": "S-Sale",
"securitiesOwned": 8184,
"reportingName": "Landry Robert E",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 1000,
"price": 72.13,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000095/0001061983-26-000095-index.htm"
},
{
"symbol": "CYTK",
"filingDate": "2026-09-15",
"transactionDate": "2026-09-14",
"reportingCik": "0001288859",
"companyCik": "0001061983",
"transactionType": "M-Exempt",
"securitiesOwned": 385320,
"reportingName": "Blum Robert I",
"typeOfOwner": "director, officer: President & CEO",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7500,
"price": 10.6,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1061983/000106198326000094/0001061983-26-000094-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "CYTK",
"senateID": "C001123",
"disclosureDate": "2026-07-03",
"transactionDate": "2026-06-30",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Cytokinetics, Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034906.pdf"
},
{
"symbol": "CYTK",
"senateID": "C001123",
"disclosureDate": "2025-11-18",
"transactionDate": "2025-10-09",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Cytokinetics, Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033455.pdf"
},
{
"symbol": "CYTK",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-17",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Cytokinetics, Incorporated - Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
},
{
"symbol": "CYTK",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-11",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Cytokinetics, Incorporated - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
}
],
"dark_pool": [
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:57:32.324000Z",
"size": 351.0,
"price": 61.733,
"premium": 21668.283,
"volume": 351.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:55:46.007000Z",
"size": 339.0,
"price": 61.54,
"premium": 20862.06,
"volume": 339.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:58:05.945000Z",
"size": 300.0,
"price": 61.95,
"premium": 18585.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:57:59.819000Z",
"size": 300.0,
"price": 61.91,
"premium": 18573.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:56:25.428000Z",
"size": 300.0,
"price": 61.605,
"premium": 18481.5,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:55:43.651000Z",
"size": 260.0,
"price": 61.61,
"premium": 16018.6,
"volume": 260.0,
"trade_code": "F"
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:56:24.046000Z",
"size": 215.0,
"price": 61.628,
"premium": 13250.02,
"volume": 215.0,
"trade_code": " "
},
{
"ticker": "CYTK",
"executed_at": "2026-10-06T14:57:19.283000Z",
"size": 200.0,
"price": 61.71,
"premium": 12342.0,
"volume": 200.0,
"trade_code": " "
}
],
"ats": {
"symbol": "CYTK",
"date": "20261005",
"ats_volume": 0,
"total_volume": 1484468,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261005",
"ats_ratio": 0.0
},
{
"date": "20261002",
"ats_ratio": 0.0
},
{
"date": "20261001",
"ats_ratio": 0.0
},
{
"date": "20260930",
"ats_ratio": 0.0
},
{
"date": "20260929",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "CYTK",
"days": [
{
"date": "2026-10-06",
"close": 61.94,
"vwap": 61.68,
"volume": 906341,
"vwap_discount_pct": -0.41
},
{
"date": "2026-10-05",
"close": 62.7,
"vwap": 63.25,
"volume": 3234412,
"vwap_discount_pct": 0.88
},
{
"date": "2026-10-02",
"close": 65.6,
"vwap": 65.23,
"volume": 2649872,
"vwap_discount_pct": -0.56
},
{
"date": "2026-10-01",
"close": 65.62,
"vwap": 65.97,
"volume": 1724383,
"vwap_discount_pct": 0.54
},
{
"date": "2026-09-30",
"close": 65.91,
"vwap": 66.09,
"volume": 2977682,
"vwap_discount_pct": 0.27
}
],
"avg_vwap_discount_pct": 0.14,
"signal": "Neutral"
},
"options_flow": [
{
"nbbo_ask": "4.40",
"price": "3.58",
"delta": "-0.4016053318939918",
"sector": "Healthcare",
"size": 50,
"expiry": "2026-11-20",
"premium": "17900.00",
"underlying_price": "61.44",
"open_interest": 214,
"underlying_symbol": "CYTK",
"volume": 101,
"implied_volatility": "0.519057538568332",
"strike": "60",
"option_chain_id": "CYTK261120P00060000",
"option_type": "put",
"nbbo_bid": "3.50",
"executed_at": "2026-10-06T13:51:09.114000Z"
},
{
"nbbo_ask": "4.40",
"price": "3.58",
"delta": "-0.4016053318939918",
"sector": "Healthcare",
"size": 49,
"expiry": "2026-11-20",
"premium": "17542.00",
"underlying_price": "61.44",
"open_interest": 214,
"underlying_symbol": "CYTK",
"volume": 51,
"implied_volatility": "0.519057538568332",
"strike": "60",
"option_chain_id": "CYTK261120P00060000",
"option_type": "put",
"nbbo_bid": "3.50",
"executed_at": "2026-10-06T13:51:09.114000Z"
}
],
"net_premium": {
"ticker": "CYTK",
"net_call_premium": "-12032.00",
"net_put_premium": "-33721.00",
"call_premium": "21276.00",
"put_premium": "39219.00",
"bullish_premium": "41012.00",
"bearish_premium": "19323.00",
"put_call_ratio": "1.3734939759036144578313253012",
"iv_rank": "9.169",
"implied_move_perc": "0.109",
"gex_ratio": "0.24571324229054368455",
"gex_net_change": "-180.9427",
"gex_call": "90435.2488",
"gex_put": "-22221.1382",
"gex_net": 68214.1106,
"gex_call_delta": "2555218.4122",
"gex_put_delta": "-614238.9108",
"gex_date": "2026-10-06"
},
"hot_chains": [
{
"underlying_symbol": "CYTK",
"expires": "2026-11-20",
"open_interest": 214,
"option_type": "put",
"delta": -0.397603972693562,
"ask_volume": 2,
"last_price": "3.58",
"implied_volatility": "0.519057538568332",
"gamma": 0.0342213555797335,
"avg_price": "3.5791089108910891089108910891",
"bid_volume": 99,
"nbbo_ask": "4.40",
"strike": "60",
"option_symbol": "CYTK261120P00060000",
"total_premium": "36149.00",
"iv": 0.5174124133675,
"volume": 101,
"nbbo_bid": "3.40"
},
{
"underlying_symbol": "CYTK",
"expires": "2027-01-15",
"open_interest": 18739,
"option_type": "call",
"delta": 0.239855169010298,
"ask_volume": 13,
"last_price": "2.45",
"implied_volatility": "0.591748047750646",
"gamma": 0.01674539849423095,
"avg_price": "2.4500000000000000000000000000",
"bid_volume": 10,
"nbbo_ask": "2.45",
"strike": "80",
"option_symbol": "CYTK270115C00080000",
"total_premium": "5635.00",
"iv": 0.569523598793189,
"volume": 23,
"nbbo_bid": "2.10"
},
{
"underlying_symbol": "CYTK",
"expires": "2026-11-20",
"open_interest": 265,
"option_type": "call",
"delta": 0.1853790885021099,
"ask_volume": 0,
"last_price": "1.02",
"implied_volatility": "0.536145612225437",
"gamma": 0.02226787254854294,
"avg_price": "1.0485714285714285714285714286",
"bid_volume": 21,
"nbbo_ask": "1.20",
"strike": "75",
"option_symbol": "CYTK261120C00075000",
"total_premium": "2202.00",
"iv": 0.550963402608044,
"volume": 21,
"nbbo_bid": "0.85"
},
{
"underlying_symbol": "CYTK",
"expires": "2026-10-16",
"open_interest": 5,
"option_type": "call",
"delta": 0.633740015527003,
"ask_volume": 0,
"last_price": "2.78",
"implied_volatility": "0.543495722109869",
"gamma": 0.0571950713802737,
"avg_price": "2.78",
"bid_volume": 10,
"nbbo_ask": "4.90",
"strike": "60",
"option_symbol": "CYTK261016C00060000",
"total_premium": "2780.00",
"iv": 0.63585281535826,
"volume": 10,
"nbbo_bid": "1.65"
},
{
"underlying_symbol": "CYTK",
"expires": "2026-11-20",
"open_interest": 1625,
"option_type": "call",
"delta": 0.276655205252431,
"ask_volume": 2,
"last_price": "1.85",
"implied_volatility": "0.52831916022803",
"gamma": 0.0299309379422852,
"avg_price": "1.8133333333333333333333333334",
"bid_volume": 7,
"nbbo_ask": "2.05",
"strike": "70",
"option_symbol": "CYTK261120C00070000",
"total_premium": "1632.00",
"iv": 0.513254380143382,
"volume": 9,
"nbbo_bid": "1.55"
},
{
"underlying_symbol": "CYTK",
"expires": "2026-11-20",
"open_interest": 104,
"option_type": "put",
"delta": -0.227592528273286,
"ask_volume": 0,
"last_price": "1.60",
"implied_volatility": "0.508780317841241",
"gamma": 0.0272443610256255,
"avg_price": "1.6416666666666666666666666666",
"bid_volume": 5,
"nbbo_ask": "1.95",
"strike": "55",
"option_symbol": "CYTK261120P00055000",
"total_premium": "985.00",
"iv": 0.508605922364842,
"volume": 6,
"nbbo_bid": "1.60"
},
{
"underlying_symbol": "CYTK",
"expires": "2027-01-15",
"open_interest": 630,
"option_type": "call",
"delta": 0.599495761929771,
"ask_volume": 0,
"last_price": "7.90",
"implied_volatility": "0.550040471210913",
"gamma": 0.02093741653550421,
"avg_price": "7.90",
"bid_volume": 6,
"nbbo_ask": "9.60",
"strike": "60",
"option_symbol": "CYTK270115C00060000",
"total_premium": "4740.00",
"iv": 0.566447356344876,
"volume": 6,
"nbbo_bid": "7.90"
},
{
"underlying_symbol": "CYTK",
"expires": "2027-01-15",
"open_interest": 1763,
"option_type": "call",
"delta": 0.398685477091928,
"ask_volume": 0,
"last_price": "4.30",
"implied_volatility": "0.563368356451208",
"gamma": 0.02061999557951625,
"avg_price": "4.3000000000000000000000000000",
"bid_volume": 6,
"nbbo_ask": "5.20",
"strike": "70",
"option_symbol": "CYTK270115C00070000",
"total_premium": "2580.00",
"iv": 0.574478561513642,
"volume": 6,
"nbbo_bid": "3.50"
}
],
"gamma_profile": {
"ticker": "CYTK",
"spot": 61.87,
"date": "2026-10-06",
"flip_point": 62.69,
"net_gex": 68214.11,
"call_walls": [
{
"strike": 80.0,
"gex": 42285.02
},
{
"strike": 70.0,
"gex": 10666.02
},
{
"strike": 65.0,
"gex": 8642.73
}
],
"put_walls": [
{
"strike": 60.0,
"gex": -8206.14
},
{
"strike": 70.0,
"gex": -3680.2
},
{
"strike": 65.0,
"gex": -3387.08
}
],
"by_strike": [
{
"strike": 17.5,
"call_gex": 1.42,
"put_gex": -0.24,
"net_gex": 1.19
},
{
"strike": 20.0,
"call_gex": 10.12,
"put_gex": -0.49,
"net_gex": 9.63
},
{
"strike": 22.5,
"call_gex": 0.13,
"put_gex": -0.46,
"net_gex": -0.34
},
{
"strike": 25.0,
"call_gex": 92.33,
"put_gex": -1.58,
"net_gex": 90.75
},
{
"strike": 30.0,
"call_gex": 66.23,
"put_gex": -8.59,
"net_gex": 57.65
},
{
"strike": 35.0,
"call_gex": 308.4,
"put_gex": -85.05,
"net_gex": 223.35
},
{
"strike": 40.0,
"call_gex": 4166.37,
"put_gex": -56.45,
"net_gex": 4109.92
},
{
"strike": 45.0,
"call_gex": 182.71,
"put_gex": -117.35,
"net_gex": 65.36
},
{
"strike": 50.0,
"call_gex": 842.16,
"put_gex": -142.75,
"net_gex": 699.41
},
{
"strike": 55.0,
"call_gex": 421.52,
"put_gex": -1807.81,
"net_gex": -1386.29
},
{
"strike": 60.0,
"call_gex": 1511.63,
"put_gex": -8206.14,
"net_gex": -6694.51
},
{
"strike": 65.0,
"call_gex": 8642.73,
"put_gex": -3387.08,
"net_gex": 5255.64
},
{
"strike": 70.0,
"call_gex": 10666.02,
"put_gex": -3680.2,
"net_gex": 6985.82
},
{
"strike": 75.0,
"call_gex": 7156.76,
"put_gex": -2426.23,
"net_gex": 4730.53
},
{
"strike": 80.0,
"call_gex": 42285.02,
"put_gex": -1470.42,
"net_gex": 40814.6
},
{
"strike": 85.0,
"call_gex": 3109.84,
"put_gex": -396.52,
"net_gex": 2713.32
},
{
"strike": 90.0,
"call_gex": 7598.48,
"put_gex": -71.17,
"net_gex": 7527.31
},
{
"strike": 95.0,
"call_gex": 429.07,
"put_gex": -76.2,
"net_gex": 352.87
},
{
"strike": 100.0,
"call_gex": 710.85,
"put_gex": -222.77,
"net_gex": 488.08
},
{
"strike": 105.0,
"call_gex": 231.18,
"put_gex": -1.86,
"net_gex": 229.32
},
{
"strike": 110.0,
"call_gex": 163.75,
"put_gex": -61.77,
"net_gex": 101.98
},
{
"strike": 115.0,
"call_gex": 136.0,
"put_gex": 0.0,
"net_gex": 136.0
},
{
"strike": 120.0,
"call_gex": 1452.49,
"put_gex": 0.0,
"net_gex": 1452.49
},
{
"strike": 125.0,
"call_gex": 250.04,
"put_gex": 0.0,
"net_gex": 250.04
}
]
},
"oi_changes": {
"net_call_oi_change": 746,
"net_put_oi_change": 0,
"top": [
{
"strike": "75",
"oi_change": 467,
"type": "call"
},
{
"strike": "70",
"oi_change": 270,
"type": "call"
},
{
"strike": "65",
"oi_change": 121,
"type": "call"
},
{
"strike": "70",
"oi_change": -70,
"type": "call"
},
{
"strike": "90",
"oi_change": -22,
"type": "call"
}
]
},
"opds": {
"opds": 23.5,
"D": 88.8,
"P": -94.3,
"O": 83.2,
"C": 26.5,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.85,
"ranked": true,
"components": {
"M": -68.4,
"T": -100.0,
"RS": -98.7,
"V": -128.2,
"F": 100.0,
"OI": 100.0,
"S": 100.0,
"IV": 88.3,
"B": null,
"Liquidity": 2.9,
"OpeningConfidence": 0.0,
"FlowAgreement": 100.0,
"StrikeBreadth": 16.7
},
"drivers": [
"- price/volume -128",
"+ aggressive flow +100",
"+ open-interest change +100",
"+ skew +100",
"- trend -100"
]
}
}
Data:
{
"vix": 16.39,
"sp500": 7666.45,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.46,
"hy_spread": 3.12,
"treasury": {
"date": "2026-10-02",
"month1": 4.04,
"month2": 4.11,
"month3": 4.19,
"month6": 4.27,
"year1": 4.46,
"year2": 4.83,
"year3": 4.96,
"year5": 5.06,
"year7": 5.17,
"year10": 5.28,
"year20": 5.67,
"year30": 5.63
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-10-07",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 1642
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 100,
"pct": 97
},
{
"name": "Woodie Pivot Touch",
"count": 96,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 93,
"pct": 90
},
{
"name": "Open Retracement",
"count": 80,
"pct": 78
},
{
"name": "Gap Fill",
"count": 78,
"pct": 76
},
{
"name": "High Vol Open",
"count": 27,
"pct": 26
},
{
"name": "Darvas Box",
"count": 27,
"pct": 26
},
{
"name": "Power Hour",
"count": 12,
"pct": 12
}
]
}